Safe and effective treatment of stroke
Acticor biotech has raised €155M across 2 funding rounds from 2 investors, most recently a Series B round in Nov 2018. Based in Paris, France; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2018-11-19 | Series B | €153M | Newton Biocapital | View deal → |
| 2017-02-01 | Early VC | €1.5M | CapDecisif Management | View deal → |
